Biopharmaceutical
Pharmaceutical
Medical
Gilead Sciences
$66.429876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$66.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.49 (2.30%) Today
+$0.02 (0.03%) As of 4:44 PM EDT after-hours
Why Robinhood?
You can buy or sell GILD and other stocks, options, ETFs, and crypto commission-free!
About GILD
Gilead Sciences, Inc. Common Stock, also called Gilead Sciences, is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Read More Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
CEO
Employees
11,000
Headquarters
Foster City, California
Founded
1987
Market Cap
82.70B
Price-Earnings Ratio
14.31
Dividend Yield
3.65
Average Volume
5.70M
High Today
$66.44
Low Today
$64.68
Open Price
$65.07
Volume
7.84M
52 Week High
$79.61
52 Week Low
$60.32
Collections
Biopharmaceutical
Pharmaceutical
Medical
Biotechnology
Health
Research And Development
Therapy
Technology
GILD News
Price Paid on Robinhood
11% Lower
Right Now
52 Week Low
$60.32
Average Price Paid
$74.70
52 Week High
$79.61
Analyst Ratings
63%
of 27 ratings
Buy
63%
Hold
33%
Sell
4%
GILD Earnings
$1.44
$1.60
$1.75
$1.91
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 30, After Hours